Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.65 - $1.25 $41,063 - $78,967
-63,174 Reduced 12.8%
430,517 $353,000
Q3 2023

Nov 14, 2023

SELL
$0.87 - $1.13 $177,748 - $230,869
-204,309 Reduced 29.27%
493,691 $437,000
Q2 2023

Aug 11, 2023

SELL
$0.81 - $1.15 $54,918 - $77,970
-67,800 Reduced 8.85%
698,000 $803,000
Q1 2023

May 12, 2023

BUY
$0.8 - $1.74 $209,932 - $456,603
262,416 Added 52.13%
765,800 $644,000
Q4 2022

Feb 13, 2023

BUY
$1.09 - $20.4 $241,090 - $4.51 Million
221,184 Added 78.38%
503,384 $654,000
Q3 2022

Nov 14, 2022

BUY
$1.7 - $20.52 $93,330 - $1.13 Million
54,900 Added 24.15%
282,200 $463,000
Q2 2022

Aug 12, 2022

BUY
$1.35 - $2.29 $123,390 - $209,306
91,400 Added 67.26%
227,300 $477,000
Q1 2022

May 13, 2022

SELL
$1.46 - $2.45 $781,279 - $1.31 Million
-535,123 Reduced 79.75%
135,900 $280,000
Q4 2021

Feb 11, 2022

BUY
$2.13 - $3.46 $1.15 Million - $1.87 Million
540,423 Added 413.8%
671,023 $1.56 Million
Q3 2021

Nov 12, 2021

SELL
$3.14 - $3.9 $707,256 - $878,439
-225,241 Reduced 63.3%
130,600 $454,000
Q2 2021

Aug 13, 2021

SELL
$3.8 - $4.56 $841,677 - $1.01 Million
-221,494 Reduced 38.36%
355,841 $1.38 Million
Q1 2021

May 13, 2021

BUY
$4.33 - $6.63 $767,860 - $1.18 Million
177,335 Added 44.33%
577,335 $2.66 Million
Q4 2020

Feb 10, 2021

BUY
$4.87 - $17.29 $1.53 Million - $5.42 Million
313,714 Added 363.57%
400,000 $2.42 Million
Q3 2020

Nov 13, 2020

BUY
$15.08 - $27.04 $281,151 - $504,133
18,644 Added 27.56%
86,286 $1.42 Million
Q2 2020

Aug 13, 2020

BUY
$14.57 - $23.96 $230,220 - $378,591
15,801 Added 30.48%
67,642 $1.58 Million
Q1 2020

May 14, 2020

SELL
$10.27 - $21.23 $1.56 Million - $3.23 Million
-152,300 Reduced 74.61%
51,841 $769,000
Q4 2019

Feb 13, 2020

BUY
$8.36 - $23.81 $661,694 - $1.88 Million
79,150 Added 63.32%
204,141 $4.18 Million
Q3 2019

Nov 13, 2019

SELL
$9.83 - $14.82 $81,677 - $123,139
-8,309 Reduced 6.23%
124,991 $1.23 Million
Q2 2019

Aug 12, 2019

BUY
$12.9 - $20.8 $1.33 Million - $2.14 Million
102,900 Added 338.49%
133,300 $1.8 Million
Q1 2019

May 14, 2019

SELL
$17.7 - $24.93 $223,020 - $314,118
-12,600 Reduced 29.3%
30,400 $599,000
Q4 2018

Feb 13, 2019

BUY
$19.05 - $36.45 $819,150 - $1.57 Million
43,000 New
43,000 $973,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.